Tech Center 1600 • Art Units: 1654 1675
This examiner grants 55% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18045317 | Antagonism of the VIP Signaling Pathway | Non-Final OA | Emory University |
| 17279228 | GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF | Non-Final OA | TAKEDA PHARMACEUTICAL COMPANY LIMITED |
| 17286857 | Netrin-1 Compounds and Compositions Thereof for Treating Pulmonary Hypertension | Final Rejection | The Regents of the University of California |
| 17904529 | OPTIMIZATION OF PEPTIDE-MELANIN BINDING | Final Rejection | UNIVERSITÉ PARIS CITÉ |
| 18030250 | COMPOSITIONS AND METHODS OF TREATING A PI3K MEDIATED DISEASE | Non-Final OA | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. |
| 17631934 | AGENT FOR PREVENTING OR TREATING MILD COGNITIVE IMPAIRMENT | Non-Final OA | NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY |
| 17631824 | MHC CLASS II MOLECULES AND METHODS OF USE THEREOF | Final Rejection | University Health Network |
| 17631820 | MHC CLASS II MOLECULES AND METHODS OF USE THEREOF | Non-Final OA | University Health Network |
| 18004233 | COMPOSITIONS HAVING NEUROREGENERATIVE APPLICATIONS | Non-Final OA | GRIFOLS WORLDWIDE OPERATIONS LIMITED |
| 17629338 | A SERIES OF INJECTABLE HYDROGELS SELF-ASSEMBLED FROM SHORT PEPTIDES FOR VARIOUS BIOMEDICAL APPLICATIONS | Non-Final OA | Agency for Science, Technology and Research |
| 17271991 | COMPOSITIONS AND METHODS FOR PROTEIN DETECTION | Non-Final OA | Syngenta Participations AG |
| 17290264 | Native whey protein for improving intestinal maturation | Non-Final OA | N.V. Nutricia |
| 17312296 | AMINO ACID HAVING FUNCTIONAL GROUP CAPABLE OF INTERMOLECULAR HYDROGEN BONDING, PEPTIDE COMPOUND CONTAINING SAME AND METHOD FOR PRODUCTION THEREOF | Final Rejection | Chugai Seiyaku Kabushiki Kaisha |
| 18602513 | COMPOSITIONS AND METHOD FOR OPTIMIZED PEPTIDE VACCINES USING RESIDUE OPTIMIZATION | Non-Final OA | Think Therapeutics, Inc. |
| 17089220 | COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF SKIN DISEASES AND DISORDERS WITH LEKTI | Non-Final OA | Azitra Inc |
| 18352101 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF WOUNDS | Non-Final OA | Imperial College Innovations Limited |
| 18003123 | FUSION PROTEIN COMPRISING ANTI-LAG-3 ANTIBODY AND IL-2, AND USE THEREOF | Non-Final OA | GI INNOVATION, INC. |
| 17911368 | PHOTORESPONSIVE PROTEIN FOR COLOR RECOGNITION AND USE THEREOF | Non-Final OA | NAGOYA INSTITUTE OF TECHNOLOGY |
| 18136803 | Sialylated Glycoproteins | Final Rejection | Momenta Pharmaceuticals, Inc. |
| 17309626 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP | Final Rejection | BicycleTx Limited |
| 17633836 | STABILIZING BUFFER FOR FACTOR VIII AND VWF | Final Rejection | OCTAPHARMA AG |
| 18006110 | ECHINOCANDIN DRUG IMPURITY, AND PREPARATION AND PURIFICATION METHODS AND USE THEREOF | Non-Final OA | Shanghai Techwell Biopharmaceutical Co., Ltd |
| 18016855 | STABLE FORMULATIONS OF ANTI-CANCER PEPTIDES | Non-Final OA | Oncolyze, Inc. |
| 18058112 | SAP AND PEPTIDOMIMETICS FOR TREATMENT OF EYE DISEASE | Non-Final OA | VIVEX BIOLOGICS GROUP, INC |
| 17416845 | NOVEL COMPOSITION | Non-Final OA | ARECOR LIMITED |
| 17915812 | POLYPEPTIDE FOR THE PROPHYLAXIS AND TREATMENT OF VIRAL INFECTIONS | Non-Final OA | PHARIS BIOTEC GMBH |
| 17905303 | TREATMENT OF VIRAL INFECTION | Non-Final OA | Pneumagen Limited |
| 17777567 | POLYPEPTIDE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Final Rejection | SHANXI JINBO BIO-PHARMACEUTICAL CO., LTD. |
| 17697110 | GLYCOSYLATED IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | Final Rejection | Ablynx N.V. |
| 17622660 | COMBINATION THERAPY METHODS, COMPOSITIONS AND KITS | Final Rejection | FUNDACIÓ DE RECERCA CLÍNIC BARCELONA-INSTITUT D’INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy